| # | Drug | Count |
|---|---|---|
| 0 | DICLOFENAC SODIUM | 3334 |
| 1 | TOCILIZUMAB | 3320 |
| 2 | DICLOFENAC | 3282 |
| 3 | METHOTREXATE SODIUM | 3282 |
| 4 | LEFLUNOMIDE | 3226 |
| 5 | ADALIMUMAB | 3220 |
| 6 | RITUXIMAB | 3199 |
| 7 | ALENDRONATE SODIUM | 3184 |
| 8 | METHOTREXATE | 3138 |
| 9 | PREDNISONE | 3108 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAFFEINE CITRATE | 669 | 0.2959 |
| 1 | TRIPROLIDINE HYDROCHLORIDE | 45 | 0.2486 |
| 2 | TRICLOSAN | 124 | 0.2322 |
| 3 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 135 | 0.2109 |
| 4 | PSEUDOEPHEDRINE HCL | 2310 | 0.2109 |
| 5 | DICLOFENAC POTASSIUM TABLETS | 1761 | 0.2103 |
| 6 | NEOMYCIN OINTMENT | 484 | 0.2035 |
| 7 | CORTISONE ACETATE | 2431 | 0.1981 |
| 8 | HYDROCORTISONE BUTYRATE | 358 | 0.1874 |
| 9 | DICLOFENAC POTASSIUM | 1761 | 0.1639 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 3511 |
| 1 | Corticosteroid [EPC] | 3479 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 3438 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3399 |
| 4 | Vitamin C [EPC] | 3252 |
| 5 | Antirheumatic Agent [EPC] | 3226 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 3221 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 3138 |
| 8 | Vitamin B12 [EPC] | 3117 |
| 9 | Aminosalicylate [EPC] | 3110 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antirheumatic Agent [EPC] | 3226 | 0.0308 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 3438 | 0.0254 |
| 2 | Interleukin-12 Antagonist [EPC] | 2495 | 0.0244 |
| 3 | Aminosalicylate [EPC] | 3110 | 0.0236 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 2990 | 0.0217 |
| 5 | Endoglycosidase [EPC] | 217 | 0.0212 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 410 | 0.0211 |
| 7 | Antiseptic [EPC] | 87 | 0.0202 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 1636 | 0.0198 |
| 9 | Tetracycline-class Drug [EPC] | 1095 | 0.0158 |